Lexicon Pharmaceuticals
LXRX
#7389
Rank
โ‚น41.02 B
Marketcap
โ‚น112.87
Share price
7.76%
Change (1 day)
78.64%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -โ‚น16.40

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น17.16. In 2024 the company made an earnings per share (EPS) of -โ‚น57.79 an increase over its 2023 EPS that were of -โ‚น72.24.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น16.40-71.62%
2024-โ‚น57.79-20%
2023-โ‚น72.2431.15%
2022-โ‚น55.08-0%
2021-โ‚น55.0810.91%
2020-โ‚น49.66-145.08%
2019โ‚น110.16-206.09%
2018-โ‚น103.84-5.74%
2017-โ‚น110.16-10.95%
2016-โ‚น123.712640%
2015-โ‚น4.51-96.34%
2014-โ‚น123.22-2.53%
2013-โ‚น126.42-9.09%
2012-โ‚น139.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,566-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น403.63-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น3,923-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น536.36 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น215.81-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น45.15 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น67.72 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น245.61-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น6,927 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA